Inference for Cumulative Incidences and Treatment Effects in Randomized Controlled Trials With Time‐to‐Event Outcomes Under ICH E9 (R1)
Statistics in Medicine · 2025
DOI: 10.1002/sim.70091 ↗At a glance
Journal article in Statistics in Medicine, 2025. Written by Yuhao Deng and 2 co-authors. Institution: Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA. Major MEDLINE topics: Randomized Controlled Trials as Topic. Cited 2 times so far (Crossref); 102 references. Funded by: National Key Research and Development Program of China, National Natural Science Foundation of China, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.
Abstract (original language)
In randomized controlled trials (RCTs) that focus on time‐to‐event outcomes, intercurrent events can arise in two ways: as semi‐competing events, which modify the hazard of the primary outcome events, or as competing events, which make the definition of the primary outcome events unclear. Although five strategies have been proposed in the ICH E9 (R1) addendum to address intercurrent events in RCTs, these strategies are not easily applicable to time‐to‐event outcomes when aiming for causal interpretations. In this study, we show how to define, estimate, and make inferences concerning objectives that have causal interpretations within these contexts. Specifically, we derive the mathematical formulations of the causal estimands corresponding to the five strategies and clarify the data structure needed to identify these causal estimands. Furthermore, we introduce nonparametric methods for estimating and making inferences about these causal estimands, including the asymptotic variance of estimators and the construction of hypothesis tests. Finally, we illustrate our methods using data from the LEADER Trial, which aims to investigate the effect of liraglutide on cardiovascular outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
- School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of Biostatistics, School of Public Health, Peking University, Beijing, China.
- Beijing International Center for Mathematical Research, Peking University, Beijing, China.
ORCID profiles: Yuhao Deng, Shasha Han, Xiao-Hua Zhou
Funding
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
- Key Research and Development Program of Jiangxi Province
- Novo Nordisk
Cite
APA
Deng, Y., Han, S., & Zhou, X. H. (2025). Inference for Cumulative Incidences and Treatment Effects in Randomized Controlled Trials With Time‐to‐Event Outcomes Under ICH E9 (R1). Statistics in Medicine. https://doi.org/10.1002/sim.70091
Vancouver
Deng Y, Han S, Zhou XH. Inference for Cumulative Incidences and Treatment Effects in Randomized Controlled Trials With Time‐to‐Event Outcomes Under ICH E9 (R1). Statistics in Medicine. 2025. doi:10.1002/sim.70091
BibTeX
@article{Deng2025,
author = {Deng, Yuhao and Han, Shasha and Zhou, Xiao-Hua},
title = {Inference for Cumulative Incidences and Treatment Effects in Randomized Controlled Trials With Time‐to‐Event Outcomes Under ICH E9 (R1)},
journal = {Statistics in Medicine},
year = {2025},
doi = {10.1002/sim.70091}
}
EUVIMED